{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:37:27Z","timestamp":1773707847407,"version":"3.50.1"},"reference-count":11,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T00:00:00Z","timestamp":1223510400000},"content-version":"vor","delay-in-days":3022,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2000,7]]},"abstract":"<jats:p>Modafinil is a novel medication recently approved for the treatment of narcolepsy and idiopathic hypersomnia. Commonly, patients had already been prescribed medications for their syndrome.<\/jats:p><jats:p>This report outlines difficulties encountered in the clinical practice of switching patients to modafinil. Na\u00efve subjects accepted modafinil best. Subjects withdrawn from amphetamine had the most problems and failure to withdraw. Venlafaxine hydrochloride combined well with modafinil to control cataplectic attacks. Usage of a progressive withdrawal protocol may ease the difficulties observed.<\/jats:p>","DOI":"10.1046\/j.1468-1331.2000.00087.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T19:36:42Z","timestamp":1047411402000},"page":"381-384","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Problems associated with switch to modafinil \u2013 a novel alerting agent in narcolepsy"],"prefix":"10.1111","volume":"7","author":[{"given":"C.","family":"Guilleminault","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. A.","family":"Aftab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Karadeniz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Philip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Leger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"77","article-title":"Validation of a cataplexy questionnaire in 923 sleep disorders patients.","volume":"22","author":"Anic\u2010Labat S","year":"1999","journal-title":"Sleep"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/17.suppl_8.S107"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.2.444"},{"key":"e_1_2_6_5_1","first-page":"57","article-title":"Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat.","volume":"288","author":"Edgar DM","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_6_1","first-page":"S137","article-title":"Modafinil induced wakefulness is attenuated in medial HDB lesioned but not SCN lesioned rat.","volume":"2","author":"Edgar DM","year":"1999","journal-title":"Sleep Res Online"},{"key":"e_1_2_6_7_1","first-page":"9","article-title":"The functional status index: reliability and validity of a self report functional disability measure.","volume":"15","author":"Jette AM","year":"1987","journal-title":"Rheumatol Supplement"},{"key":"e_1_2_6_8_1","first-page":"519","article-title":"A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale.","volume":"9","author":"Johns MA","year":"1991","journal-title":"Sleep"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.24.14128"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430115"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/16.8.706"},{"key":"e_1_2_6_12_1","first-page":"817","article-title":"Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs.","volume":"18","author":"Shelton J","year":"1995","journal-title":"Sleep"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1468-1331.2000.00087.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-1331.2000.00087.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T14:43:50Z","timestamp":1698590630000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1468-1331.2000.00087.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["10.1046\/j.1468-1331.2000.00087.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-1331.2000.00087.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]},"assertion":[{"value":"2008-10-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}